Published in Reumatismo on December 01, 2005
Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol Cell Biol (1985) 4.14
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis (2010) 2.40
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med (1995) 2.07
Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol (2012) 2.02
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis (2004) 1.80
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Leishmania in SLE mimicking an exacerbation. Clin Exp Rheumatol (2006) 1.54
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum (2005) 1.49
AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest. Bone Marrow Transplant (2010) 1.46
Systemic sclerosis and multiple sclerosis. J Neurol (1999) 1.45
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study. Clin Exp Rheumatol (2002) 1.42
Cardiac involvement in Behçet's disease. Cardiology (1998) 1.42
Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ (2004) 1.42
Do Behçet's syndrome patients with acne and arthritis comprise a true subset? Comment on the article by Hatemi et al. Arthritis Rheum (2009) 1.40
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters. Rev Rhum Engl Ed (1996) 1.38
Biological and clinical effects of anti-TNFalpha treatment. Autoimmun Rev (2007) 1.28
IgG subclasses in human hydatid disease: prominence of the IgG4 response. Int Arch Allergy Immunol (1993) 1.22
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
Stringency without ppGpp accumulation. Nature (1981) 1.22
Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol (2010) 1.21
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Gastric parietal cell antibodies: demonstration by immunofluorescence of their reactivity with surface of the gastric parietal cells. Clin Exp Immunol (1980) 1.16
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol (2004) 1.16
Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int (2000) 1.14
Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. Gastroenterology (1991) 1.12
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12
Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin Exp Immunol (2000) 1.11
Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol (1985) 1.10
Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab (1995) 1.09
Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis (2006) 1.08
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemost (1990) 1.07
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun (1994) 1.06
Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharm Pharmacol (1997) 1.06
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis (2011) 1.05
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis (2005) 1.04
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol (2003) 1.04
Computed tomography and thymoma: distinctive findings in invasive and noninvasive thymoma and predictive features of recurrence. Radiol Med (2009) 1.02
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis (2002) 0.99
Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clin Exp Rheumatol (1996) 0.99
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum (2011) 0.98
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford) (2008) 0.98
Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology (1995) 0.98
Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus (1993) 0.97
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C. Aliment Pharmacol Ther (2002) 0.97
Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease. Clin Exp Immunol (1997) 0.97
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96
Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood (2000) 0.96
Ultrasound imaging for the rheumatologist. XXIV. Sonographic evaluation of wrist and hand joint and tendon involvement in systemic lupus erythematosus. Clin Exp Rheumatol (2010) 0.96
Morphological and secretory properties of bronchoalveolar lavage mast cells in respiratory diseases. Clin Allergy (1986) 0.96
Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol (1996) 0.95
Accuracy of CT-guided transthoracic needle biopsy of lung lesions: factors affecting diagnostic yield. Radiol Med (2007) 0.95
Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol (2007) 0.94
Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies. Clin Exp Immunol (1985) 0.94
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum (2010) 0.94
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus (1995) 0.93
Histamine release test in the diagnosis of human hydatidosis. Clin Exp Allergy (1989) 0.93
Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis (2010) 0.93
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. BMJ (1990) 0.92
Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis. Ann Rheum Dis (2008) 0.91
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Ann Rheum Dis (2008) 0.90
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation. Clin Exp Immunol (2015) 0.90
Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus. Lupus (1993) 0.90
New radiopharmaceuticals for imaging rheumatoid arthritis. Q J Nucl Med Mol Imaging (2006) 0.90
Sonography in the study of metatarsalgia. J Rheumatol (2001) 0.90
Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist. Pharmazie (2016) 0.90
Ultrasound imaging for the rheumatologist II. Ultrasonography of the hand and wrist. Clin Exp Rheumatol (2006) 0.90
Ultrasound imaging for the rheumatologist VII. Ultrasound imaging in rheumatoid arthritis. Clin Exp Rheumatol (2007) 0.89
Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods (1994) 0.89
Involvement of autoimmunity in the pathogenesis of aggressive periodontitis. J Dent Res (2010) 0.89
Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis. Ann Rheum Dis (2008) 0.88
Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol (2000) 0.88
Markers of vascular injury in Behçet's disease associated with retinal vasculitis. Ann Ophthalmol (1992) 0.88
Circulating immune complexes in sera of patients infected with Echinococcus granulosus. Clin Exp Immunol (1983) 0.88
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol (2005) 0.88
Ultrasonography of salivary glands in primary Sjögren's syndrome: a comparison with contrast sialography and scintigraphy. Rheumatology (Oxford) (2008) 0.88
Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies. Clin Exp Immunol (1981) 0.88
Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis (2005) 0.88
Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol (1999) 0.88
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Ann Ist Super Sanita (1999) 0.87
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon. Hepatogastroenterology (1997) 0.87
Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies. Thromb Haemost (1996) 0.87
Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus. Clin Rheumatol (2003) 0.87